We’ve made sure that our patients are preserved in a way that gives you maximum peace of mind.
Preservation life stores its patients at the European Biostasis Foundation’s underground facility in Switzerland. This facility was specially designed for long-term stability and security. Switzerland was chosen due to its security, socio-economic stability, strict oversight of non-profits, and low risk of natural disasters.
We’re actively working on improving human cryopreservation and increasing the chances for future revival.
There is no time limit to how long you can be cryopreserved for, both from a biological and a financial standpoint. The majority of cryopreservation funds go to a patient care trust called the Tomorrow Patient Foundation (TPF). The TPF puts the funds into very low risk investments that yield 1-2% above inflation every year. This return is more than enough to pay for the running costs of keeping patients cryopreserved. With this system, our patients can remain in cryopreservation for however long it takes until future medical technology can treat them. This is the same system that has been used to successfully keep patients cryopreserved in the US for over 50 years, despite multiple financial crises.
All funds for the cryopreservation procedure and indefinite long-term storage of a patient must be available (via life insurance, etc.) at the time of their legal death. Nothing is paid after a patient is in cryopreservation. Our plans already include all the funds needed for indefinite long-term storage, as explained in the question above.
No, for safety reasons it isn’t possible to visit the facility. However, members are invited to an annual event at the facility.
No, for safety reasons we can’t allow visitors at the facility.
Cryopreserved patients would not be affected by a power outage. Only liquid nitrogen (no electricity) is used to maintain cryopreservation, which secures the patients against power outages.
Our cryopreservation plans were carefully constructed with the long-term security of patients in mind, so they would be unaffected if Tomorrow were to cease operations. Tomorrow’s cryopreserved patients are stored at the European Biostasis Foundation (EBF) in Switzerland. EBF is a non-profit organization with complete financial independence. The funds to keep patients cryopreserved are managed by a patient care trust which is a non-profit private benefit organization. This means that cryopreserved patients would not be affected if Tomorrow ever ceased its operations.
The European Biostasis Foundation (EBF) is a Swiss non-profit organization which means it’s subject to more strict governmental oversight than non-profit’s in most other countries. Specifically, the Swiss government ensures that non-profit’s stay mission aligned and do not change from the purpose for which they were founded. This means that EBF must stay true to it’s mission to advance Biostasis science and provide secure long-term storage. Additionally, EBF’s statutes and bylaws are optimized for long-term stability (i.e. vote quorums, self amending board). EBF is entirely financially independent from Tomorrow Bio and receives regular generous donations for its research endeavours. All members of the board of EBF are highly intrinsically motivated with a long-term involvement in the field and receive no financial incentive for their board position.
People involved in the management of the Tomorrow Patient Foundation (TPF) must be signed up for cryopreservation and/or have loved ones currently in cryopreservation. Additionally, members of the TPF receive no financial compensation which means the organization has no overhead costs and only attracts people who are highly intrinsically motivated to keep our cryopreserved patient stable and secure.
